POS0621 DISEASE-SPECIFIC ADVERSE DRUG REACTION PROFILES OF ADALIMUMAB AND ETANERCEPT AS REPORTED BY IMMUNE-MEDIATED INFLAMMATORY DISEASE PATIENTS
Sign Up to like & getrecommendations! Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.2300
Abstract: Background: Information on adverse drug reactions (ADRs) is generally clustered for all indications of a drug in the patient information leaflet. However, previous research has shown that participants of the Dutch Biologic Monitor (DBM) that… read more here.
Keywords: submitted work; outside submitted; research; none declared ... See more keywords
POS0271-HPR PATIENT PERSPECTIVE ON A DRUG SAFETY MONITORING SYSTEM FOR IMMUNE-MEDIATED INFLAMMATORY DISEASES BASED ON PATIENT-REPORTED OUTCOMES
Sign Up to like & getrecommendations! Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.635
Abstract: Patient-reported outcomes (PROs) on adverse drug reactions (ADRs) are increasingly used in cohort event monitoring (CEM) to obtain a better understanding of patient’s real-world experience with drugs. Despite the leading role for patients, little is… read more here.
Keywords: drug safety; submitted work; outside submitted; safety monitoring ... See more keywords